LYNDSI SLUSARSKI: Open Payments
NPI 1356373930 · RAPID CITY, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$690 in 24 payments from 12 companies in 2025. Trend: 2023 $613 · 2024 $419 · 2025 $690
Food & beverage: $618Education: $72
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $302 |
| GENZYME CORPORATION | 3 | $75 |
| SANOFI-AVENTIS U.S. LLC | 1 | $72 |
| Amgen Inc. | 3 | $69 |
| Regeneron Healthcare Solutions, Inc. | 1 | $31 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Janssen Biotech, Inc. | 1 | $25 |
| UCB, Inc. | 1 | $20 |
| Galderma Laboratories, L.P. | 1 | $19 |
| Arcutis Biotherapeutics, Inc. | 1 | $18 |
Products named: BOTOX, DUPIXENT, SKYRIZI, Otezla, RINVOQ, LIBTAYO, COSENTYX, TREMFYA.
Industry payments across SD — which companies pay providers there.
